RIFASUTENIZOL
UNII 2G83RZK9U6

Substance Identification & Data

This profile provides standardized clinical and technical data for Rifasutenizol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2G83RZK9U6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1001314-13-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2G83RZK9U6

CAS Registry Number

1001314-13-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RIFASUTENIZOL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C48H61N7O13

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

GVNMWVKTEANXFY-AIGATTFSSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C190354

National Cancer Institute reference terminology for clinical and research data.

INN ID

12337

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C12=C3C(=NC4(N3)CCN(CC4)CCn5c(ncc5[N+](=O)[O-])C)c6c(C1=O)c(c(c7O[C@@](C(c67)=O)(O/C=C/[C@@H]([C@@H](C)[C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@H](/C=C/C=C(\C(N2)=O)/C)C)O)C)O)C)OC(=O)C)OC)C)C)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rifasutenizol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RIFASUTENIZOL

Common Names & Synonyms

RIFASUTENIZOL [INN]

Systematic Nomenclature

(9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-16-(ACETYLOXY)-6,18,20-TRIHYDROXY-14-METHOXY-7,9,15,17,19,21,25-HEPTAMETHYL-1'-(2-(2-METHYL-5-NITRO-1H-IMIDAZOL-1-YL)ETHYL)SPIRO(9,4-(EPOXYPENTADECA(1,11,13)TRIENIMINO)-2H-FURO(2',3':7,8)NAPHTH(1,2-D)IMIDAZOLE-2,4'-PIPERIDINE)-5,10,26(3H,9H)-TRIONE

SYS

SPIRO(9,4-(EPOXYPENTADECA(1,11,13)TRIENIMINO)-2H-FURO(2',3':7,8)NAPHTH(1,2-D)IMIDAZOLE-2,4'-PIPERIDINE)-5,10,26(3H,9H)-TRIONE, 16-(ACETYLOXY)-6,18,20-TRIHYDROXY-14-METHOXY-7,9,15,17,19,21,25-HEPTAMETHYL-1'-(2-(2-METHYL-5-NITRO-1H-IMIDAZOL-1-YL)ETHYL)-, (9S,12E,14S,15R,16S,17R,18R,19R,20S,21S,22E,24Z)-

SYS

Technical Codes

TNP-2198

External Clinical & Regulatory Resources

Previous UNII2G83E641HZ

Next UNII2G84433G4O